![Andrew Karaplis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Karaplis
Corporate Officer/Principal chez McGill University
Postes actifs de Andrew Karaplis
Sociétés | Poste | Début | Fin |
---|---|---|---|
McGill University | Corporate Officer/Principal | 15/10/2009 | - |
Historique de carrière de Andrew Karaplis
Anciens postes connus de Andrew Karaplis
Sociétés | Poste | Début | Fin |
---|---|---|---|
Osta Biotechnologies, Inc.
![]() Osta Biotechnologies, Inc. BiotechnologyHealth Technology Osta Biotechnologies, Inc. was a life sciences firm that focused on the development of novel therapeutic products for cancer and alzheimer's disease. The company has also developed a pipe line of novel diagnostic and therapeutic products for alzheimer's disease, osteoporosis, osteoarthritis and xlinked hypophosphatemic rickets. Osta Biotechnologies was founded by Ajay Gupta and Andrew Karaplis on January 9, 2004 and is headquartered in Dollard-des-Ormeaux, Canada. | Directeur/Membre du Conseil | 13/10/2010 | - |
Directeur Technique/Scientifique/R&D | 15/10/2009 | - | |
Fondateur | 09/01/2004 | - | |
President | 09/01/2004 | - |
Statistiques
Internationale
Canada | 3 |
Opérationnelle
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Osta Biotechnologies, Inc.
![]() Osta Biotechnologies, Inc. BiotechnologyHealth Technology Osta Biotechnologies, Inc. was a life sciences firm that focused on the development of novel therapeutic products for cancer and alzheimer's disease. The company has also developed a pipe line of novel diagnostic and therapeutic products for alzheimer's disease, osteoporosis, osteoarthritis and xlinked hypophosphatemic rickets. Osta Biotechnologies was founded by Ajay Gupta and Andrew Karaplis on January 9, 2004 and is headquartered in Dollard-des-Ormeaux, Canada. | Health Technology |
- Bourse
- Insiders
- Andrew Karaplis
- Expérience